Repare Therapeutics

$9.06 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Repare Therapeutics

Repare Therapeutics Inc is a Canada-based precision oncology company targeting specific vulnerabilities of tumors in genetically defined patient populations. Its approach integrates discoveries from several fields of cell biology including deoxyribonucleic acid (DNA) repair and synthetic lethality. Its SNIPRx platform combines a clustered regularly interspaced short palindromic repeats (CRISPR)-enabled gene editing target discovery method with protein crystallography, computational biology and clinical informatics.

Stock Analysis

last close $9.06
1-mo return -21%
3-mo return -40.4%
avg daily vol. 196.15T
52-week high 35.75
52-week low 8.42
market cap. $367M
forward pe -
annual div. -
roe -45.7%
ltg forecast -
dividend yield -
annual rev. $8M
inst own. 91.7%

Subscribe now for daily local and international financial news